Nicotine dependence is common among drug and alcohol dependent patients. This multi-site trial evaluated the effectiveness of smoking-cessation treatment with transdermal nicotine patch replacement (SC) as an adjunct to treatment-as-usual for illicit substance abuse (TAU). Cigarette smokers from five methadone-maintenance clinics and two drug and alcohol dependence treatment programs were randomly assigned to receive either SC as an adjunct to usual care or TAU. SC consisted of 1 week of group counseling before the target quit date and 8 weeks of group counseling plus transdermal nicotine patch replacement treatment after the target quit date.
Principal Investigator(s)
John Rotrosen, M.D.
Professor
NYU School of Medicine
Department of Psychiatry
One Park Avenue, 8th Floor
New York, NY 10016
john.rotrosen@nyumc.org
Participating Sites
- Mount Sinai Medical Center, New York
- Narco Freedom, Inc., New York
- St. Luke's Roosevelt Hospital Center
- Daymark Recovery Services, Inc., New York
- Matrix Institute on Addictions, California
- Tarzana Treatment Center, California
- Behavioral Health Services of Pickens County, South Carolina
- Coastal Horizons Center, Inc., North Carolina